| scholarly article | Q13442814 |
| P50 | author | William R. Markesbery | Q56850445 |
| D Allan Butterfield | Q66912067 | ||
| P2093 | author name string | Jeffrey N. Keller | |
| Hafiz Mohmmad Abdul | |||
| Rukhsana Sultana | |||
| Daret K. St Clair | |||
| P2860 | cites work | The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain | Q48104045 |
| Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells | Q48211649 | ||
| NMDA-dependent superoxide production and neurotoxicity | Q48234286 | ||
| Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice | Q48308608 | ||
| Intrahippocampal injection of kainic acid produces significant pyramidal cell loss in neonatal rats | Q48345859 | ||
| Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model | Q48381823 | ||
| Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease | Q48482673 | ||
| The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex | Q48747391 | ||
| Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice | Q48846848 | ||
| Kainate-induced apoptotic cell death in hippocampal neurons. | Q51620778 | ||
| Evidence that Aβ42 is the real culprit in alzheimer's disease | Q53201642 | ||
| Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. | Q53226236 | ||
| Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid | Q57243601 | ||
| The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction† | Q58842885 | ||
| Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo | Q28131779 | ||
| Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders | Q28202177 | ||
| Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy | Q28281986 | ||
| Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease | Q29614374 | ||
| Oxidative stress in synaptosomal proteins from mutant presenilin-1 knock-in mice: implications for familial Alzheimer's disease. | Q30330445 | ||
| Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. | Q31101732 | ||
| Proteomic identification of nitrated proteins in Alzheimer's disease brain | Q31144652 | ||
| Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures | Q31968497 | ||
| The role of excitotoxicity in neurodegenerative disease: implications for therapy | Q33639170 | ||
| Translating cell biology into therapeutic advances in Alzheimer's disease | Q33678168 | ||
| The role of oxidative stress in Alzheimer disease | Q33791940 | ||
| Intracellular biology of Alzheimer's disease amyloid beta peptide | Q33827283 | ||
| Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. | Q33887952 | ||
| Molecular basis of Alzheimer's disease | Q33966679 | ||
| Reactive oxygen species, cell signaling, and cell injury | Q33991757 | ||
| Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo | Q34063772 | ||
| Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide | Q34456855 | ||
| Glutamate neurotoxicity and diseases of the nervous system | Q34560997 | ||
| Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress | Q34657995 | ||
| Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death | Q34976924 | ||
| Increased apoptotic cell death in sporadic and genetic Alzheimer's disease | Q35700403 | ||
| Mechanisms of neuronal degeneration in Alzheimer's disease | Q40986730 | ||
| Oxidative DNA damage in human respiratory tract epithelial cells. Time course in relation to DNA strand breakage | Q41185956 | ||
| Alzheimer's disease: genotypes, phenotypes, and treatments | Q41340438 | ||
| Hydrogen peroxide mediates amyloid beta protein toxicity | Q41460857 | ||
| Oxidative stress hypothesis in Alzheimer's disease | Q41482152 | ||
| Kainic acid induced seizures: neurochemical and histopathological changes | Q42447130 | ||
| Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation | Q43565734 | ||
| The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. | Q43681037 | ||
| Domoic acid-induced hippocampal CA1 hyperexcitability independent of region CA3 activity | Q43774633 | ||
| Caspase-3-associated apoptotic cell death in excitotoxic necrosis of the entorhinal cortex following intraperitoneal injection of kainic acid in the rat. | Q43906715 | ||
| Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. | Q44158605 | ||
| Protective effect of the xanthate, D609, on Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells | Q45006835 | ||
| Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease | Q45046608 | ||
| APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease | Q45047098 | ||
| Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity | Q45247861 | ||
| Oxygen free radicals in rat limbic structures after kainate-induced seizures. | Q45975207 | ||
| Oxidative stress induced by glutamate receptor agonists | Q46126472 | ||
| Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease | Q46414475 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oxidative stress | Q898814 |
| Amyloid beta (A4) precursor protein | Q14865884 | ||
| Presenilin 1 | Q21496912 | ||
| P304 | page(s) | 1322–1335 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implication | |
| P478 | volume | 96 |
| Q46142593 | A cross-sectional study on cerebrospinal fluid biomarker levels in cognitively normal elderly subjects with or without a family history of Alzheimer's disease. |
| Q42910540 | A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's disease. |
| Q36725255 | A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury |
| Q33712475 | Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease |
| Q49762112 | Alzheimer's disease hypothesis and related therapies |
| Q37111515 | Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression |
| Q37773826 | Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications |
| Q36976873 | An update of animal models of Alzheimer disease with a reevaluation of plaque depositions |
| Q50051252 | Carvedilol protection against endogenous Aβ-induced neurotoxicity in N2a cells. |
| Q42099415 | Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein |
| Q36993185 | Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease |
| Q41663079 | G206D Mutation of Presenilin-1 Reduces Pen2 Interaction, Increases Aβ42/Aβ40 Ratio and Elevates ER Ca(2+) Accumulation. |
| Q48604859 | Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology |
| Q34306241 | Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease |
| Q42920869 | In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. |
| Q47871329 | Inhibitory effects of Tabernaemontana divaricata root extract on oxidative stress and neuronal loss induced by amyloid β25-35 peptide in mice |
| Q36808464 | Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. |
| Q36538283 | Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease |
| Q37749683 | Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects |
| Q35606693 | Mitochondrial medicine for aging and neurodegenerative diseases |
| Q51760895 | Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease. |
| Q41121746 | Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. |
| Q37101305 | Oxidative stress and the pathogenesis of Alzheimer's disease |
| Q34561160 | Oxidative stress in Alzheimer disease: synergy between the Butterfield and Markesbery laboratories |
| Q33639885 | Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis |
| Q35748709 | Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease |
| Q38440340 | Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model |
| Q42397173 | Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cog |
| Q38793564 | Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age |
| Q46342470 | RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs-Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia |
| Q39168195 | Recent advances in the Overman rearrangement: synthesis of natural products and valuable compounds. |
| Q36525171 | Redox proteomics in some age-related neurodegenerative disorders or models thereof |
| Q26740342 | Role of ROS and RNS Sources in Physiological and Pathological Conditions |
| Q36633918 | Secrets of the lac operon. Glucose hysteresis as a mechanism in dietary restriction, aging and disease |
| Q91970893 | Susceptibility to cellular stress in PS1 mutant N2a cells is associated with mitochondrial defects and altered calcium homeostasis |
| Q26827320 | The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment |
| Q61810306 | The Protective Effects of PSM-04 Against Beta Amyloid-Induced Neurotoxicity in Primary Cortical Neurons and an Animal Model of Alzheimer's Disease |
| Q38012450 | The bad, the good, and the ugly about oxidative stress. |
| Q36381106 | Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease. |
Search more.